FDA Counterfeit Task Force Continues Work On Wholesaler “Best Practices”

FDA's Counterfeit Drug Task Force is continuing to gather information from the drug wholesaler industry on "best practices" for reducing the risk of counterfeits in the pharmaceutical supply chain